Pediatrics in Maine: Fall 2021 Educational Series - 10-5

Reducing the Burden of Influenza on Children...

Presented by Jesse Papenburg, MDCM, MSc, FRCPC

Question Title

* 1. Will this activity enhance your competence or encourage you do anything differently after attending?

Yes

No

Optional - share an example:

Question Title

* 2. Will this activity influence your practice or patient outcomes?

Yes

No

Not sure

Comment:

Question Title

* 3. Was the presence of faculty conflict of interest or commercial support provided to the audience prior to the activity?

Yes

No

N/A

If yes, please specify:

Question Title

* 4. Please share your impressions of the speaker and presentation by rating the following:

	Excellent	Good	Fair	Poor
Presentation Style	Presentation Style Excellent	Presentation Style Good	Presentation Style Fair	Presentation Style Poor
Knowledge of Material	Knowledge of Material Excellent	Knowledge of Material Good	Knowledge of Material Fair	Knowledge of Material Poor
Relevance of Topic	Relevance of Topic Excellent	Relevance of Topic Good	Relevance of Topic Fair	Relevance of Topic Poor
Connection with Audience	Connection with Audience Excellent	Connection with Audience Good	Connection with Audience Fair	Connection with Audience Poor

Comments:

Question Title

* 5. After participating in this activity, how often do you plan to do the following?

	Never	Infrequently	Sometimes	Frequently	Always
Begin antiviral therapy within 48 hours for pediatric patients with confirmed or suspected influenza	Begin antiviral therapy within 48 hours for pediatric patients with confirmed or suspected influenza Never	Begin antiviral therapy within 48 hours for pediatric patients with confirmed or suspected influenza Infrequently	Begin antiviral therapy within 48 hours for pediatric patients with confirmed or suspected influenza Sometimes	Begin antiviral therapy within 48 hours for pediatric patients with confirmed or suspected influenza Frequently	Begin antiviral therapy within 48 hours for pediatric patients with confirmed or suspected influenza Always
Remain aware of the latest clinical evidence for novel and emerging antiviral therapies for children with influenza	Remain aware of the latest clinical evidence for novel and emerging antiviral therapies for children with influenza Never	Remain aware of the latest clinical evidence for novel and emerging antiviral therapies for children with influenza Infrequently	Remain aware of the latest clinical evidence for novel and emerging antiviral therapies for children with influenza Sometimes	Remain aware of the latest clinical evidence for novel and emerging antiviral therapies for children with influenza Frequently	Remain aware of the latest clinical evidence for novel and emerging antiviral therapies for children with influenza Always

Question Title

* 6. If you are seeking CME, please attest below:

I watched the entire hour long webinar.

Yes

No

Question Title

* 7. Provide your full name and credentials and your email address.

Name

Email Address